Bioadaptives Stock Fundamentals
| BDPT Stock | USD 0.10 0.02 16.67% |
BioAdaptives fundamentals help investors to digest information that contributes to BioAdaptives' financial success or failures. It also enables traders to predict the movement of BioAdaptives Pink Sheet. The fundamental analysis module provides a way to measure BioAdaptives' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioAdaptives pink sheet.
BioAdaptives |
BioAdaptives Company Shares Outstanding Analysis
BioAdaptives' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current BioAdaptives Shares Outstanding | 160.49 M |
Most of BioAdaptives' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioAdaptives is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, BioAdaptives has 160.49 M of shares currently outstending. This is 61.46% lower than that of the Consumer Defensive sector and 38.08% lower than that of the Packaged Foods industry. The shares outstanding for all United States stocks is 71.93% higher than that of the company.
BioAdaptives Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioAdaptives's current stock value. Our valuation model uses many indicators to compare BioAdaptives value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioAdaptives competition to find correlations between indicators driving BioAdaptives's intrinsic value. More Info.BioAdaptives is number one stock in return on asset category among its peers. It is rated below average in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioAdaptives' earnings, one of the primary drivers of an investment's value.BioAdaptives Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioAdaptives' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BioAdaptives could also be used in its relative valuation, which is a method of valuing BioAdaptives by comparing valuation metrics of similar companies.BioAdaptives is currently under evaluation in shares outstanding category among its peers.
BioAdaptives Fundamentals
| Return On Asset | -3.43 | |||
| Operating Margin | (33.58) % | |||
| Current Valuation | 544.74 K | |||
| Shares Outstanding | 160.49 M | |||
| Shares Owned By Insiders | 7.39 % | |||
| Price To Earning | (14.28) X | |||
| Price To Sales | 7.53 X | |||
| Revenue | 19.78 K | |||
| Gross Profit | 10.11 K | |||
| EBITDA | (643.76 K) | |||
| Net Income | (1.05 M) | |||
| Cash And Equivalents | 49.58 K | |||
| Total Debt | 450.26 K | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (158.65 K) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | -0.29 | |||
| Market Capitalization | 144.44 K | |||
| Total Asset | 148.59 K | |||
| Retained Earnings | (2.96 M) | |||
| Working Capital | (160 K) | |||
| Current Asset | 156 K | |||
| Current Liabilities | 316 K | |||
| Z Score | -41.0 | |||
| Net Asset | 148.59 K |
About BioAdaptives Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioAdaptives's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioAdaptives using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioAdaptives based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada. Bioadaptives operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 3 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.